Astex Pharmaceuticals is pleased to share the below news which was today Issued by its collaborator The Institute of Cancer Research, London,
MHRA approves first-in-class breast cancer drug
• MHRA approves first-in-class drug Truqap (capivasertib) in combination with fulvestrant for treating HR-positive, HER-2 negative locally advanced breast cancer with specific biomarker alterations (PIK3CA, AKT1 or PTEN) alterations following recurrence or progression on or after an endocrine based regimen
Protagene has added cell based bioassay driven structure-function correlation to its extensive portfolio of MS and biophysical methods. Non GMP assays are available immediately, with GMP level assays becoming available in August.
To discuss this or any other analytical requirements, please contact colin.crowley@protagene.com
Cambridge, UK – July 17th 2024 - The Cambridge Crystallographic Data Centre (CCDC) is excited to highlight that its CSD-Particle suite of advanced informatics tools is now being actively used to revolutionize the understanding of particle behaviour and surface properties in pharmaceutical and fine chemical manufacturing. The suite provides easy to use digital methods to enhance the efficiency of product formulation and reduce manufacturing costs.
Pharmaron's DMPK Insights Podcast Episode #8: “It’s ‘All-go’ with Oligos: Challenges and Opportunities in LC-MS of Therapeutics.”
Menopause care provider Minter Hormone Health wins Femtech and Women’s Health competition
The Femtech & Women’s Health edition of ‘Discovery Spark’ supports early stage businesses working to close the gender health gap
Anglia Innovation Partnership, the campus management organisation at Norwich Research Park, hosted its latest Enterprise Tuesday event on Tuesday 11 June at the John Innes Conference Centre, showcasing novel technology platforms and debating the value of ‘science push and industry pull’ activity in the cluster.
CCDC Scientist Awarded Prestigious BACG Young Scientists Award
Dr Pietro Sacchi Wins the Award for Ground-Breaking Work Providing Practical Solutions to Long-Standing Challenges in Drug Development and Manufacturing
Cambridge, UK – 12 July 2024 – We are pleased to announce that Dr Pietro Sacchi, Research and Application Scientist at the CCDC, has been awarded the British Association for Crystal Growth (BACG) Young Scientists Award for his exceptional research on the HIV drug ritonavir.
The pharmaceutical landscape is evolving rapidly, and staying ahead requires a deep understanding of the current trends and challenges. This comprehensive report provides a critical analysis of the drug development industry, focusing on the health of pipelines, the strategic focus of biotechs and pharmacos, and the capacity of regulators like the FDA to manage the influx of novel therapies.
AMSBIO offers a wide range of products to support skeletal muscle cell culture enabling you to streamline your modelling process in vitro.